BackEvelo Biosciences Overview

Evelo Biosciences Selling, General & Admin

Evelo Biosciences selling, general & admin — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$3.89M
45.4% YoY

As of Sep 30, 2023

Annual SG&A Expenses (TTM)

$20.85M
37.92% YoY

Trailing 12 months ending Sep 30, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Evelo Biosciences (EVLO) FAQ

Stockcircle tracks selling, general & admin for Evelo Biosciences (EVLO), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Evelo Biosciences's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main EVLO overview so you can move from this figure to the surrounding analysis quickly.